Bristol-Myers Squibb
BMY
BMY
2,526 hedge funds and large institutions have $126B invested in Bristol-Myers Squibb in 2022 Q2 according to their latest regulatory filings, with 152 funds opening new positions, 961 increasing their positions, 1,062 reducing their positions, and 96 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 2,505 → 2,526 (+21)
0.48% more ownership
Funds ownership: 76.72% → 77.19% (+0.48%)
10% less repeat investments, than reductions
Existing positions increased: 961 | Existing positions reduced: 1,062
Holders
2,526
Holding in Top 10
132
Calls
$2.58B
Puts
$1.98B
Top Buyers
| 1 | +$1.42B | |
| 2 | +$1.17B | |
| 3 | +$663M | |
| 4 |
N
Natixis
Paris,
France
|
+$375M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$374M |
Top Sellers
| 1 | -$666M | |
| 2 | -$521M | |
| 3 | -$294M | |
| 4 |
SOMRS
State of Michigan Retirement System
Lansing,
Michigan
|
-$247M |
| 5 |
IFP
Independent Franchise Partners
London,
United Kingdom
|
-$205M |